review Open AccessTop 1% cited
COVID-19: Melatonin as a potential adjuvant treatment
Life Sciences · 2020 · Vol. 250 · pp. 117583–117583
Rui Zhang(Peking Union Medical College Hospital)Xuebin Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)Leng Ni(Peking Union Medical College Hospital)Di Xiao(Peking Union Medical College Hospital)Baitao Ma(Chinese Academy of Medical Sciences & Peking Union Medical College)Shuai Niu(Chinese Academy of Medical Sciences & Peking Union Medical College)Changwei Liu✉(Peking Union Medical College Hospital)Rüssel J. Reiter✉(The University of Texas Health Science Center at San Antonio)
Circadian rhythm and melatoninDietary Effects on HealthCOVID-19 and Mental HealthMelatoninCytokine stormARDSMedicinePathogenesisDiffuse alveolar damageImmunologyImmune systemPandemicCoronavirus disease 2019 (COVID-19)
MeSH terms
BetacoronavirusCOVID-19SARS-CoV-2COVID-19 Drug TreatmentAdjuvants, ImmunologicAnti-Inflammatory AgentsAntioxidantsHumansInflammationMelatoninPneumonia, ViralRespiratory Distress SyndromeCytokinesCoronavirus InfectionsAcute Lung Injury
Citations
633
FWCI
56.52
field-weighted impact
References
93
Percentile
100%
vs. same field & year
Citations per year
Cited by
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
Archives of Disease in Childhood · 2020 · 529 citations
References
Origin and evolution of pathogenic coronaviruses
Nature Reviews Microbiology · 2018 · 5,807 citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The Lancet · 2020 · 51,571 citations
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
The Lancet · 2020 · 22,618 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.